vs
FGI Industries Ltd.（FGI）与ARS Pharmaceuticals, Inc.（SPRY）财务数据对比。点击上方公司名可切换其他公司
FGI Industries Ltd.的季度营收约是ARS Pharmaceuticals, Inc.的1.1倍（$30.5M vs $28.1M），FGI Industries Ltd.净利率更高（-8.6% vs -147.1%，领先138.5%），FGI Industries Ltd.同比增速更快（-14.4% vs -67.6%）
FGI Industries Ltd是一家全球厨卫产品、家居收纳解决方案及家装用品的设计、制造与分销商，服务覆盖北美、欧洲及亚太地区的大型连锁零售商、家居专营店和电商平台。
ARS Pharmaceuticals是一家处于后期研发阶段的生物制药企业，专注于开发和商业化严重过敏反应创新疗法，核心产品为无需注射的肾上腺素鼻腔递送制剂，主要面向北美市场，服务存在致命过敏风险的成人及儿童患者群体。
FGI vs SPRY — 直观对比
营收规模更大
FGI
是对方的1.1倍
$28.1M
营收增速更快
FGI
高出53.2%
-67.6%
净利率更高
FGI
高出138.5%
-147.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $30.5M | $28.1M |
| 净利润 | $-2.6M | $-41.3M |
| 毛利率 | 26.7% | — |
| 营业利润率 | -2.2% | -147.6% |
| 净利率 | -8.6% | -147.1% |
| 营收同比 | -14.4% | -67.6% |
| 净利润同比 | -553.1% | -182.8% |
| 每股收益（稀释后） | $-1.63 | $-0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FGISPRY
| Q4 25 | $30.5M | $28.1M | ||
| Q3 25 | $35.8M | $32.5M | ||
| Q2 25 | $31.0M | $15.7M | ||
| Q1 25 | $33.2M | $8.0M | ||
| Q4 24 | $35.6M | $86.6M | ||
| Q3 24 | $36.1M | $2.1M | ||
| Q2 24 | $29.4M | $500.0K | ||
| Q1 24 | $30.8M | $0 |
净利润FGISPRY
| Q4 25 | $-2.6M | $-41.3M | ||
| Q3 25 | $-1.7M | $-51.2M | ||
| Q2 25 | $-1.2M | $-44.9M | ||
| Q1 25 | $-629.1K | $-33.9M | ||
| Q4 24 | $-402.3K | $49.9M | ||
| Q3 24 | $-550.1K | $-19.1M | ||
| Q2 24 | $163.6K | $-12.5M | ||
| Q1 24 | $-412.2K | $-10.3M |
毛利率FGISPRY
| Q4 25 | 26.7% | — | ||
| Q3 25 | 26.5% | — | ||
| Q2 25 | 28.1% | — | ||
| Q1 25 | 26.8% | — | ||
| Q4 24 | 24.6% | — | ||
| Q3 24 | 25.8% | — | ||
| Q2 24 | 30.5% | — | ||
| Q1 24 | 27.4% | — |
营业利润率FGISPRY
| Q4 25 | -2.2% | -147.6% | ||
| Q3 25 | 1.0% | -163.7% | ||
| Q2 25 | -2.7% | -302.9% | ||
| Q1 25 | -3.9% | -466.3% | ||
| Q4 24 | -3.5% | 54.5% | ||
| Q3 24 | -0.2% | -1051.6% | ||
| Q2 24 | -1.5% | -3068.0% | ||
| Q1 24 | -1.0% | — |
净利率FGISPRY
| Q4 25 | -8.6% | -147.1% | ||
| Q3 25 | -4.6% | -157.4% | ||
| Q2 25 | -4.0% | -285.6% | ||
| Q1 25 | -1.9% | -425.7% | ||
| Q4 24 | -1.1% | 57.7% | ||
| Q3 24 | -1.5% | -925.0% | ||
| Q2 24 | 0.6% | -2503.2% | ||
| Q1 24 | -1.3% | — |
每股收益（稀释后）FGISPRY
| Q4 25 | $-1.63 | $-0.41 | ||
| Q3 25 | $-0.86 | $-0.52 | ||
| Q2 25 | $-0.64 | $-0.46 | ||
| Q1 25 | $-0.07 | $-0.35 | ||
| Q4 24 | $-0.38 | $0.52 | ||
| Q3 24 | $-0.29 | $-0.20 | ||
| Q2 24 | $0.08 | $-0.13 | ||
| Q1 24 | $-0.04 | $-0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.9M | $245.0M |
| 总债务越低越好 | — | $96.4M |
| 股东权益账面价值 | $17.3M | $114.3M |
| 总资产 | $69.5M | $327.7M |
| 负债/权益比越低杠杆越低 | — | 0.84× |
8季度趋势，按日历期对齐
现金及短期投资FGISPRY
| Q4 25 | $1.9M | $245.0M | ||
| Q3 25 | $1.9M | $288.2M | ||
| Q2 25 | $2.5M | $240.1M | ||
| Q1 25 | $1.2M | $275.7M | ||
| Q4 24 | $4.6M | $314.0M | ||
| Q3 24 | $3.0M | $204.6M | ||
| Q2 24 | $1.3M | $218.7M | ||
| Q1 24 | $3.3M | $223.6M |
总债务FGISPRY
| Q4 25 | — | $96.4M | ||
| Q3 25 | — | $96.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益FGISPRY
| Q4 25 | $17.3M | $114.3M | ||
| Q3 25 | $19.7M | $147.7M | ||
| Q2 25 | $21.3M | $192.3M | ||
| Q1 25 | $21.8M | $229.0M | ||
| Q4 24 | $22.3M | $256.8M | ||
| Q3 24 | $23.5M | $201.0M | ||
| Q2 24 | $23.8M | $215.2M | ||
| Q1 24 | $23.9M | $223.9M |
总资产FGISPRY
| Q4 25 | $69.5M | $327.7M | ||
| Q3 25 | $73.0M | $372.8M | ||
| Q2 25 | $71.7M | $313.5M | ||
| Q1 25 | $68.5M | $327.3M | ||
| Q4 24 | $75.5M | $351.2M | ||
| Q3 24 | $74.7M | $217.6M | ||
| Q2 24 | $69.9M | $222.0M | ||
| Q1 24 | $68.6M | $227.6M |
负债/权益比FGISPRY
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.3M | $-43.5M |
| 自由现金流经营现金流 - 资本支出 | $2.3M | — |
| 自由现金流率自由现金流/营收 | 7.5% | — |
| 资本支出强度资本支出/营收 | 0.2% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-212.5K | — |
8季度趋势，按日历期对齐
经营现金流FGISPRY
| Q4 25 | $2.3M | $-43.5M | ||
| Q3 25 | $-1.9M | $-47.0M | ||
| Q2 25 | $7.6M | $-39.6M | ||
| Q1 25 | $-7.4M | $-40.7M | ||
| Q4 24 | $617.4K | $42.0M | ||
| Q3 24 | $-915.0K | $-14.5M | ||
| Q2 24 | $862.1K | $-7.3M | ||
| Q1 24 | $-8.0M | $-6.7M |
自由现金流FGISPRY
| Q4 25 | $2.3M | — | ||
| Q3 25 | $-2.1M | $-47.2M | ||
| Q2 25 | $7.4M | $-39.6M | ||
| Q1 25 | $-7.7M | $-40.8M | ||
| Q4 24 | $-214.1K | $41.7M | ||
| Q3 24 | $-1.1M | $-14.6M | ||
| Q2 24 | $281.5K | $-7.3M | ||
| Q1 24 | $-8.6M | $-6.8M |
自由现金流率FGISPRY
| Q4 25 | 7.5% | — | ||
| Q3 25 | -5.9% | -145.4% | ||
| Q2 25 | 23.8% | -252.2% | ||
| Q1 25 | -23.3% | -512.1% | ||
| Q4 24 | -0.6% | 48.2% | ||
| Q3 24 | -3.0% | -706.3% | ||
| Q2 24 | 1.0% | -1463.4% | ||
| Q1 24 | -28.0% | — |
资本支出强度FGISPRY
| Q4 25 | 0.2% | 0.0% | ||
| Q3 25 | 0.7% | 0.6% | ||
| Q2 25 | 0.7% | 0.3% | ||
| Q1 25 | 1.1% | 1.1% | ||
| Q4 24 | 2.3% | 0.3% | ||
| Q3 24 | 0.5% | 6.8% | ||
| Q2 24 | 2.0% | 7.6% | ||
| Q1 24 | 2.0% | — |
现金转化率FGISPRY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.27× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FGI
| Sanitaryware | $19.1M | 63% |
| Shower System | $5.8M | 19% |
| Kitchen And Bath Other | $3.3M | 11% |
| Bath Furniture Products | $2.3M | 7% |
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
